Template for Reporting Results of Biomarker Testing of Specimens From Patients With Melanoma

Affiliations

• ¹ From the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Sholl);
• ² the Department of Pathology, University of Michigan Hospitals, Ann Arbor (Dr Andea);
• ³ the Department of Pathology, University of Nebraska Medical Center, Omaha (Dr Bridge);
• ⁴ the Department of Pathology, Indiana University, Indianapolis (Dr Cheng);
• ⁵ the Departments of Melanoma Medical Oncology and Systems Biology (Dr Davies).
• ⁶ Pathology (Drs Lazar and Siroy), and Translational Molecular Pathology (Dr Lazar).
• ⁷ The University of Texas MD Anderson Cancer Center, Houston, Texas; Newport Coast Pathology Inc, Newport Beach, California (Dr Ehteshami);
• ⁸ the Department of Medicine and the Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia (Dr Gangadhar);
• ⁹ the Department of Pathology, The University Health Network/Princess Margaret Cancer Center, Toronto, Ontario, Canada (Dr Kamel-Reid);
• ¹⁰ the Department of Pathology, Northwestern University, Chicago, Illinois (Dr Raparia); and Cancer Registry Consultant, Sioux Falls, South Dakota (Ms Watson).
• ¹¹ and Cancer Registry Consultant, Sioux Falls, South Dakota (Ms Watson).